Close
  Indian J Med Microbiol
 

Figure 3: Repeat OCT at 3 months confirming complete SRF resolution under the fovea 3 months' post-bevazizumab (a); nasal resolution of SRF post focal laser (b); follow-up OCT at 1 year with foveal thinning and no recurrence of SRF (c)

Figure 3: Repeat OCT at 3 months confirming complete SRF resolution under the fovea 3 months' post-bevazizumab (a); nasal resolution of SRF post focal laser (b); follow-up OCT at 1 year with foveal thinning and no recurrence of SRF (c)